Trial · NCT02329158
Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery
NCT02329158, Completed, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery. Trials, record NCT02329158. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02329158
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery
- NCT number
- NCT02329158
- Status
- Completed
- Enrollment
- 2,000 participants, actual
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions
- Cardiac Surgical Procedures
- Interventions
- 6% hydroxyethyl starch
- First posted
- 2014-12-31
- Last updated
- 2018-11-06
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Length of Stay | Following cardiac surgery (on average approximately 10 days) | Acute hospital length of stay (in days) following cardiac surgery |
| Secondary | Rates of transfusion | During or after cardiac surgery, prior to hospital discharge (on average approximately 10 days) | The proportion receiving a transfusion of red blood cells or other products. |
| Secondary | Rates of transfusion | During or after cardiac surgery, prior to hospital discharge (on average approximately 10 days) | The number of units of red blood cells or other products transfused. |
| Secondary | Kidney Injury | During or after cardiac surgery, prior to hospital discharge (on average approximately 10 days) | The proportion experiencing kidney injury as measured by serum creatinine levels. |
| Secondary | Renal Replacement Therapy | During or after cardiac surgery, prior to hospital discharge (on average approximately 10 days) | The proportion receiving renal replacement therapy. |
| Secondary | Cost of care | During the acute phase of the hospital stay (on average approximately 10 days) | The total cost of the acute phase of hospitalization based on hospital case cost data. |
| Secondary | In-hospital mortality | Death during the hospital stay (on average approximately 10 days) | The proportion dying during the hospital stay. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30411246 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02329158
GET https://conductscience.org/api/trials/v1/NCT02329158/registered